Background and aims The prevalence of chronic hepatitis B virus (HBV) infection in Europe is poorly defined. Data on the proportion of patients eligible for therapy are lacking but are crucial to meet WHO elimination goals. The aims of our study were to provide an estimate of the need for antiviral treatment and to assess the prevalence of advanced liver disease in treatment-naive, chronic HBV-infected patients. Patients and methods We performed a retrospective, cross-sectional analysis of all treatment-naive HBV-infected patients. Baseline clinical assessments included sociodemographic data, hepatitis B-specific analyses, and liver stiffness measurement (LSM). Results Between 2010 and 2017, 465 patients with chronic HBV infection were refe...
Introduction: Nationwide studies are mandatory to assess changes in the epidemiology of HBV infectio...
International audienceHepatitis B virus (HBV) infection remains a global public health problem with ...
It is estimated that one-third of the world’s population has been exposed to hepatitis B virus and t...
GOALS:: To characterize the clinical and treatment pattern in a large population of hepatitis B viru...
Background and aims: The uptake of antiviral treatment for patients with chronic hepatitis B (CHB) h...
AbstractThe prevalence and management of chronic hepatitis B virus (HBV) infection differ among Euro...
Background & Aims: Among people living with HBV, only a subset of individuals with chronic hepat...
Goals: To characterize the clinical and treatment pattern in a large population of hepatitis B virus...
BACKGROUND: Between 350 and 400 million people worldwide have chronic hepatitis B virus (HBV) infec...
The prevalence and management of chronic hepatitis B virus (HBV) infection differ among European cou...
International audienceAbstract Background Treatment eligibility and the accuracy of its simplified c...
1. Introduction Chronic hepatitis B virus (HBV) infection currently affects about 400 million peopl...
BACKGROUND: Limited information exists regarding the distribution of disease phases, treatment presc...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Introduction: Nationwide studies are mandatory to assess changes in the epidemiology of HBV infectio...
International audienceHepatitis B virus (HBV) infection remains a global public health problem with ...
It is estimated that one-third of the world’s population has been exposed to hepatitis B virus and t...
GOALS:: To characterize the clinical and treatment pattern in a large population of hepatitis B viru...
Background and aims: The uptake of antiviral treatment for patients with chronic hepatitis B (CHB) h...
AbstractThe prevalence and management of chronic hepatitis B virus (HBV) infection differ among Euro...
Background & Aims: Among people living with HBV, only a subset of individuals with chronic hepat...
Goals: To characterize the clinical and treatment pattern in a large population of hepatitis B virus...
BACKGROUND: Between 350 and 400 million people worldwide have chronic hepatitis B virus (HBV) infec...
The prevalence and management of chronic hepatitis B virus (HBV) infection differ among European cou...
International audienceAbstract Background Treatment eligibility and the accuracy of its simplified c...
1. Introduction Chronic hepatitis B virus (HBV) infection currently affects about 400 million peopl...
BACKGROUND: Limited information exists regarding the distribution of disease phases, treatment presc...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Introduction: Nationwide studies are mandatory to assess changes in the epidemiology of HBV infectio...
International audienceHepatitis B virus (HBV) infection remains a global public health problem with ...
It is estimated that one-third of the world’s population has been exposed to hepatitis B virus and t...